RET, ret proto-oncogene, 5979

N. diseases: 607; N. variants: 162
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Multiple Endocrine Neoplasia Type 2a
0.800 Biomarker disease GENOMICS_ENGLAND
Multiple Endocrine Neoplasia Type 2a
0.800 Biomarker disease BEFREE Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. 11073534 2000
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2A (MEN 2A) is associated with specific germline missense mutations in the RET proto-oncogene. 11979448 2002
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2A (MEN 2A) is associated with specific germ-line missense mutations in the RET proto-oncogene. 12702567 2003
Multiple Endocrine Neoplasia Type 2a
0.800 Biomarker disease CTD_human Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are genetic diseases due to activating mutations of the RET proto-oncogene. 12864791 2003
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2A (MEN 2A) and familial medullary thyroid carcinoma (FMTC) are genetic diseases due to activating mutations of the RET proto-oncogene. 12864791 2003
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. 16343738 2006
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 is due to a germline mutation in the RET proto-oncogene. 16857415 2006
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is a rare autosomal dominantly inherited familial cancer syndrome caused by mutations in the ret proto-oncogene. 17551473 2006
Multiple Endocrine Neoplasia Type 2a
0.800 Biomarker disease BEFREE Multiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations. 19177457 2009
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer predisposition syndrome, and > 95% of MEN 2 patients carry rearranged during transfection (RET) protooncogene mutants. 19443294 2009
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary cancer syndrome caused by missense gain-of-function mutations of the RET proto-oncogene. 20083156 2010
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is a genetic syndrome caused by germline mutations in the RET proto-oncogene. 20497437 2011
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is a genetic disease characterized by medullary thyroid carcinoma (MTC) associated (MEN 2A and 2B) or not familial MTC (FMTC) with other endocrine neoplasia due to germline RET gene mutations. 20516206 2010
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 is characterized by germline mutations in RET. 20979234 2011
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 and a subset of apparently sporadic medullary thyroid carcinoma (AS-MTC) are caused by germ line activating point mutations of the rearranged during transfection (RET) proto-oncogene. 21551259 2011
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 is historically composed of three clinical subtypes, all of which are associated with germline mutations in the RET proto-oncogene. 21552134 2011
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is a genetic disorder caused by mutation in the RET proto-oncogene. 26457501 2015
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 kindred with novel tandem RET mutations: Case report with an applied in silico mutational tolerance analysis. 26876062 2016
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant genetic syndrome caused by germline mutation in RET proto-oncogene. 26884116 2016
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer syndrome caused by mutations in the RET protooncogene. 8605678 1996
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes. 11839664 2002
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease LHGDN RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. 11935126 2002
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. 11935126 2002
Multiple Endocrine Neoplasia Type 2a
0.800 GeneticVariation disease BEFREE RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome. 12788868 2003